BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 28946063)

  • 1. Hetero-multivalent binding of cholera toxin subunit B with glycolipid mixtures.
    Krishnan P; Singla A; Lee CA; Weatherston JD; Worstell NC; Wu HJ
    Colloids Surf B Biointerfaces; 2017 Dec; 160():281-288. PubMed ID: 28946063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding Cooperativity Matters: A GM1-Like Ganglioside-Cholera Toxin B Subunit Binding Study Using a Nanocube-Based Lipid Bilayer Array.
    Worstell NC; Krishnan P; Weatherston JD; Wu HJ
    PLoS One; 2016; 11(4):e0153265. PubMed ID: 27070150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of cholera toxin-ganglioside interactions by flow cytometry.
    Lauer S; Goldstein B; Nolan RL; Nolan JP
    Biochemistry; 2002 Feb; 41(6):1742-51. PubMed ID: 11827518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanodiscs for immobilization of lipid bilayers and membrane receptors: kinetic analysis of cholera toxin binding to a glycolipid receptor.
    Borch J; Torta F; Sligar SG; Roepstorff P
    Anal Chem; 2008 Aug; 80(16):6245-52. PubMed ID: 18616345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanodomain Formation of Ganglioside GM1 in Lipid Membrane: Effects of Cholera Toxin-Mediated Cross-Linking.
    Sun H; Chen L; Gao L; Fang W
    Langmuir; 2015 Aug; 31(33):9105-14. PubMed ID: 26250646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformational changes in cholera toxin B subunit-ganglioside GM1 complexes are elicited by environmental pH and evoke changes in membrane structure.
    McCann JA; Mertz JA; Czworkowski J; Picking WD
    Biochemistry; 1997 Jul; 36(30):9169-78. PubMed ID: 9230049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modifications of cholera toxin subunit B binding to human large intestinal epithelium. An immunohistochemical study.
    Kirkeby S; Lynge Pedersen AM
    Microb Pathog; 2018 Nov; 124():332-336. PubMed ID: 30145256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GM1 clustering inhibits cholera toxin binding in supported phospholipid membranes.
    Shi J; Yang T; Kataoka S; Zhang Y; Diaz AJ; Cremer PS
    J Am Chem Soc; 2007 May; 129(18):5954-61. PubMed ID: 17429973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescence analysis of galactose, lactose, and fucose interaction with the cholera toxin B subunit.
    Mertz JA; McCann JA; Picking WD
    Biochem Biophys Res Commun; 1996 Sep; 226(1):140-4. PubMed ID: 8806604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid lateral mobility and membrane phase structure modulation by protein binding.
    Forstner MB; Yee CK; Parikh AN; Groves JT
    J Am Chem Soc; 2006 Nov; 128(47):15221-7. PubMed ID: 17117874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposome fluidity alters interactions between the ganglioside GM1 and cholera toxin B subunit.
    Terrell J; Yadava P; Castro C; Hughes J
    J Liposome Res; 2008; 18(1):21-9. PubMed ID: 18348069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel GM1 ganglioside-like peptide mimics prevent the association of cholera toxin to human intestinal epithelial cells in vitro.
    Yu RK; Usuki S; Itokazu Y; Wu HC
    Glycobiology; 2016 Jan; 26(1):63-73. PubMed ID: 26405107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of the binding of cholera toxin to GM1 gangliosides on solid supported lipid bilayer vesicles and inhibition by europium (III) chloride.
    Williams TL; Jenkins AT
    J Am Chem Soc; 2008 May; 130(20):6438-43. PubMed ID: 18412339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholera toxin binds to lipid rafts but has a limited specificity for ganglioside GM1.
    Blank N; Schiller M; Krienke S; Wabnitz G; Ho AD; Lorenz HM
    Immunol Cell Biol; 2007 Jul; 85(5):378-82. PubMed ID: 17325693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissecting the cholera toxin-ganglioside GM1 interaction by isothermal titration calorimetry.
    Turnbull WB; Precious BL; Homans SW
    J Am Chem Soc; 2004 Feb; 126(4):1047-54. PubMed ID: 14746472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholera toxin B-mediated targeting of lipid vesicles containing ganglioside GM1 to mucosal epithelial cells.
    Lian T; Ho RJ
    Pharm Res; 1997 Oct; 14(10):1309-15. PubMed ID: 9358541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholera toxin assault on lipid monolayers containing ganglioside GM1.
    Miller CE; Majewski J; Faller R; Satija S; Kuhl TL
    Biophys J; 2004 Jun; 86(6):3700-8. PubMed ID: 15189866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of multivalent protein-ligand binding kinetics by second-harmonic correlation spectroscopy.
    Sly KL; Conboy JC
    Anal Chem; 2014 Nov; 86(22):11045-54. PubMed ID: 25314127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell membrane array fabrication and assay technology.
    Yamazaki V; Sirenko O; Schafer RJ; Nguyen L; Gutsmann T; Brade L; Groves JT
    BMC Biotechnol; 2005 Jun; 5():18. PubMed ID: 15960850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights into binding of cholera toxin to GM1 containing membrane.
    Basu I; Mukhopadhyay C
    Langmuir; 2014 Dec; 30(50):15244-52. PubMed ID: 25425333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.